Dr. Reddy's Laboratories Adjusts Evaluation Amidst Mixed Market Performance and Growth Metrics
Dr. Reddy's Laboratories has recently experienced a change in evaluation, reflecting a shift in its market position. The company has shown resilience with a 13.13% annual growth rate in net sales and a 31.97% increase in operating profit, while maintaining a low debt-to-equity ratio and strong institutional holdings.
Dr. Reddy's Laboratories, a prominent player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in evaluation. This revision reflects a shift in the technical landscape surrounding the stock, indicating a transition from a bullish to a mildly bullish trend. The company's current stock price stands at 1222.00, slightly above the previous close of 1220.60. Over the past year, Dr. Reddy's has experienced a return of -12.21%, contrasting with a modest gain of 0.05% in the broader market. Despite this, the company has demonstrated resilience with a notable annual growth rate in net sales of 13.13% and an operating profit growth of 31.97%.
Dr. Reddy's Laboratories maintains a low debt-to-equity ratio, averaging at 0 times, and has achieved a return on equity of 15.68%, highlighting its profitability. The stock is currently trading at a fair value compared to its peers, supported by high institutional holdings at 63.1%.
This evaluation adjustment underscores the ongoing dynamics within the company and the market, reflecting a nuanced view of its performance metrics and market position.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
